The Role of Smoking in Cocaine. Addiction

Similar documents
BRAIN MECHANISMS OF REWARD AND ADDICTION

Council on Chemical Abuse Annual Conference November 2, The Science of Addiction: Rewiring the Brain

The Molecular Basis of Drug Addiction Vulnerability

National Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says

MOLECULAR BIOLOGY OF DRUG ADDICTION. Sylvane Desrivières, SGDP Centre

The Biology of Addiction Eric J. Nestler

On the historic occasion of the 122nd Shattuck Lecture and

Transcriptional and Epigenetic Mechanisms of Addiction

Understanding Addiction and Its Impact on the Brain. SDSMA Webinar Matthew Stanley, DO

At a Glance. Background Information. Lesson 3 Drugs Change the Way Neurons Communicate

Understanding Addiction: Why Can t Those Affected Just Say No?

The Biology of Addiction

Ken Winters, Ph.D. Department of Psychiatry University of Minnesota Midwest Conference on Problem Gambling August 11, 2004

590,000 deaths can be attributed to an addictive substance in some way

Effects of Drugs on the Brain and Behavior in Adolescents

The Neurobiology of Addiction

Understanding Addiction

Dr. Solomon Derese. Department of Chemistry University of Nairobi

Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP

Possession by evil spirits? Demon rum. Lack of moral fiber? War on drugs Just say no

America is a drugged society

The Brain, Behavior and Addiction National Family Dialogue January 27, 2010 Presenter: Flo Hilliard, MSH University of Wisconsin-Madison

The Neurobiology of Addiction. Angela Haliburda, DO

Psychoactive drugs Drugs which affect mental processes. Legal but restricted (by prescription only)

Jim Giese, Ph.D., LP Affiliated Clinical Services

,, : Current Status in Drug Addiction and Addiction Memory Research WAN G Hao2Ran 1, GAO Xiang2 Rong 1, ZHAN G Kai2Gao 2, HAN Ji2Sheng 1 ( 1

The Biological Perspective. Jørg Mørland Senior researcher, Norwegian Institute of Public Health Professor em of Medicine University of Oslo

Cigarettes and Other Nicotine Products

The Neurobiology of Drug Addiction

If you give any person a prescription of something like Valium and have them take it on

General introduction. Chapter 1

The Neuroscience of Addiction: A mini-review

ADHD & Addictions -What We Know

Drugs, addiction, and the brain

Brain Imaging studies in substance abuse. Jody Tanabe, MD University of Colorado Denver

processes in the central nervous system (CNS), affecting many of the during the course of ethanol treatment. Ethanol stimulates the release of

Taken From The Brain Top to Bottom //

Neurobiology of Addiction

Cellular Mechanisms of Learning and the Biological Basis of Individuality

The Adolescent Developmental Stage

Main Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders

Psychoactive Drugs & The Brain

CHAPTER 2. THE NEUROBIOLOGY OF SUBSTANCE USE, MISUSE, AND ADDICTION

WHAT SHOULD WE KNOW ABOUT MARIJUANA

11/7/2016. Possession by evil spirits? Demon rum. Lack of moral fiber? War on drugs Just say no

The Addicted Brain. Abstract. 1 Introduction. Eric J. Nestler and Robert C. Malenka. March 2004

Understanding the Brain: What Drugs Can Tell Us

Modeling Neurotransmission and Drugs. CHM 108 Lab. Spring Dr. Angela King

How Addiction Affects the Brain: The Neuroscience of Compulsive Behavior

Management of Tobacco Dependence. Dr. Lokesh Kumar Singh Associate Professor Department of Psychiatry AIIMS, Raipur

Prefrontal dysfunction in drug addiction: Cause or consequence? Christa Nijnens

OPIOID ADDICTION AND THE BRAIN MICHAEL NERNEY AND ASSOCIATES P.O. BOX 93 LONG LAKE, NY

Schizophrenic twin. Normal twin

Drugs, The Brain, and Behavior

Psychotropic Drugs Critical Thinking - KEY

Relationship Between Stress and Substance Use Disorders: Neurobiologic Interface

Cell body, axon, dendrite, synapse

Neuroscience of Addiction

Drugs, Brain and Behavior

Effects of Marijuana On Brain, Body & Behavior. Nora D. Volkow, MD Director

MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER

Key Concepts. Machinery of the Mind. The Growing Cycle. Six Brain Mind Functions. Machinery of the Mind 6/1/2012

ThinkTwice! Genetic Analysis Shows Gene Expression is Changed by Cocaine (Part II) JOURNAL ARTICLE TEI PLAIN LANGUAGE ANTHOLOGY C C

Effects of Marijuana On Brain, Body & Behavior. Nora D. Volkow, M.D. Director

nucleus accumbens septi hier-259 Nucleus+Accumbens birnlex_727

Physical and Physiological Aspects of Drug Use and Abuse

Brain Reward Pathway and Addiction

Molecular Biology of Memory Storage: The Persistence of Memory

Linking Neuroscience, Developmental Psychology, and Personal Experience To Help Understand Addiction

Cocaine-mediated Induction and Gene Targets of Hippocampal FosB

Cocaine. How Is Cocaine Abused? How Does Cocaine Affect the Brain?

Neurobiology of addiction and why it is important

Initiation of Smoking and Other Addictive Behaviors: Understanding the Process

What are Substance Use Disorders?

Nicotine Decreases Ethanol-induced Dopamine Signaling and Increases Self-administration via Steroid Hormones

MeCP2 and psychostimulantinduced behavioral adaptations. Anne E. West, M.D., Ph.D. Department of Neurobiology Duke University Medical Center

Marijuana. How is Marijuana Abused? How Does Marijuana Affect the Brain?

CASE 49. What type of memory is available for conscious retrieval? Which part of the brain stores semantic (factual) memories?

Activity 1: Connections

The Human Animal Drugs of Plant Origin

Teen Mental Health and Substance Abuse. Cheryl Houtekamer AHS - AADAC Youth Services Calgary

The Neurobiology of Street Drugs. Joe Gilboy PA-C Hoag Hospital Emergency Department Irvine, CA. Neuroplasticity. Question #1

It s Not Just Drug Addiction! Howard Wetsman MD DFASAM Chief Medical Officer Townsend Treatment

Epigenetics: The Future of Psychology & Neuroscience. Richard E. Brown Psychology Department Dalhousie University Halifax, NS, B3H 4J1

Introduction and Background

Part IV: Slipping Up: Neuroscience Basis of Relapse & Recovery July 31, am 12:30 pm with Break 10-10:15am

Scientific Facts on. Psychoactive Drugs. Tobacco, Alcohol, and Illicit Substances

Brain Health and Opioid Abuse

Learning outcomes: Keeping it Real and Safe: What Every School Counselor Should Know About Underage Drinking

Discover the Hope: Opiate Treatment and Recovery

Psychology 210. Chemical Messengers. Types of NTs. Properties of Neurotransmitters. Cholinergic Neurons. Small molecule NTs.

The Neurochemistry of Relapse & Recovery Worksheets to accompany the video by CNS Productions, Inc.

Addiction in the Brain - Latest Research. Gary M. Henschen, MD, LFAPA Chief Behavioral Health Officer Magellan Healthcare, Inc.

PERSPECTIVE. Is there a common molecular pathway for addiction? Eric J Nestler NEUROBIOLOGY OF ADDICTION

Understanding Addiction and Dugs Of Abuse

Neurobiology of Addiction. Jon E. Grant, JD, MD, MPH Professor University of Chicago

SMOKELESS TOBACCO IN THE CONTEXT OF TOBACCO HARM REDUCTION

Neurobiology of Substance and Gambling Addictions

Abstracts and affiliations

Cogs 107b Systems Neuroscience lec9_ neuromodulators and drugs of abuse principle of the week: functional anatomy

Transcription:

The Role of Smoking in Cocaine Addiction Luca Colnaghi Eric Kandel Laboratory Columbia University in the City of New York Department of Neuroscience

Index 1- The Brain, memory, metaplasticity 2- Cocaine Addiction 3- The Gateway Hypothesis 4- Experimental evidence supporting the Gateway Hypothesis References

1- The Brain, memory, metaplasticity The brain is the most complex and less understood organ in our body. It is formed by billions of cells that dynamically interact to control most, if not all, aspects of our life and define who we are. A very dynamic organ, it is not complete at birth, but keeps growing during childhood and fully matures only after adolescence. And continues to evolve throughout life, allowing us to adapt to the environment around us and our experiences. This ability of the brain to dynamically evolve is defined brain plasticity. Although considered a single tissue, the brain is characterized by different, but interconnected, regions that have specific functions (Fig 1). Fig 1 The Brain is characterized by several interconnected regions For instance, the olfactory bulb is involved in the perception of odors, the amygdala plays a major role in processing emotions, the hippocampus is involved in memory forming and storing while the region responsible for reward, pleasure but also for addictive phenotype is

the striatum (Fig 2). Fig 2 The Striatum is a brain region that regulates reward and addictive phenotypes. The Nucleus Accumbens (N. Acc) and the Ventral Tegmental Area (VTA) are considered the center of addiction. One of the most remarkable aspects of the brain, and something that has fascinated philosophers, writers and scientists for centuries, is its ability to create memories. An aspect that only now we are starting to understand. The brain encodes for two general types of memories: short term memory and long term memory. Although the two processes share common mechanisms, they are also profoundly different. Short term memory, as the name suggests, is a transient process that does not require expression of new genes or synthesis of new proteins. At any given time all the components required for short term memory are present in neurons. However, this memories do not last for a very long time (between minutes to hours) but they can be transformed in long term memories when needed. Long term memories are thought to be stored in the bioelectrical field generated by networks or circuits

of neurons, and the learning process (meaning how we learn that something has happened) is regulated by the strength of the connections between this neurons. While short term memories do not change the strength of synapses, long term memories do, allowing the brain to remember specific facts or events. The transformation of short term memories to long term memories requires expression of new genes, alterations in the chromatin structure in the nucleus and growth and maintenance of new synaptic connections requiring activation of local protein synthesis at the synapse. This dynamic process is called synaptic plasticity or more in general brain plasticity (Kandel ER 2012). More recently however, scientists have discovered that the current plasticity state of synapses also depends on their history and they named this phenomenon metaplasticity. Technically, metaplasticity ascertains that certain past experiences change synaptic architecture and neural circuitry in the brain so that when another event comes along it is experienced differently than if the past experience did not occur. Genes and Proteins Expression The DNA in the nucleus is organized in a three dimensional structure called chromatin, formed by the DNA itself and specific proteins called histones. The DNA has a high chemical affinity for the histones and it wraps around them (Fig 3).

Fig 3 The DNA is organized in a three dimensional structure called chromatin The role of the histones is not only to organized the DNA but also to regulate the expression of the encoded genes by masking them (Fig 4). Fig 4 Histones regulate gene expression. To activate a gene, specific enzymes called histone acetyltransferases bind the histones and

displace them, allowing the DNA to be seen by the transcriptional machinery and the genes to be expressed. Histone deacetylases (HDAC), on the other hand, suppress gene expression by increasing the number of histones bound to the DNA (Fig 5). Gene expression creates mrna that is next translated into proteins in the cytoplasm. Fig 5 Histone acetyltransferase (HAT) and histone deacetylases (HDACs) regulate histone affinity to DNA and gene expression. 2- Cocaine Addiction

The 2010 National Survey on Drug Use and Health reported that almost 37 million Americans, 12 years of age or older, have tried cocaine in their lifetime, and 5.7 million have used it in the past year making cocaine the second most commonly used drug of abuse in the United States. The reasons for its popularity are its immediate psychological effects. Snorted or injected cocaine induces self-confidence, euphoria and good feelings, magnifying the intensity of almost all normal pleasures. However, cocaine use also causes medical complications like respiratory failure, cardiovascular and gastrointestinal problems and paranoia. Moreover, after prolonged exposure, individuals become addicted to it, losing control over use of the drug and engaging in destructive behavior related to cocaine procurement. Cocaine addiction is a chronic relapsing condition with high risk of medical complications, cognitive impairment, financial ruin and social issues. At the cellular level, cocaine increases the available quantity of the neurotransmitter dopamine in the brain, thereby inducing immediate euphoria and pleasure. Dopamine, produced by dopaminergic neurons, controls the activity of dopamine responsive nerve cells, which are particularly abundant in a series of interconnected brain regions that form the mesolimbic dopamine system. In the latter, dopamine stimulates several regions, among them the striatum to produce feelings of reward. Thus, by altering the levels of dopamine in the striatum, cocaine creates intense pleasure and euphoria. Aside from the striatum, the limbic system contains other regions that are critical substrates for the neural adaptations that underlie addiction. In particular, the amygdala and the hippocampus play a role in memory formation and storage. These regions create long lasting memories of the intense pleasure and the environment associated with drug use, which will

later trigger the desire to repeat the experience and lead to addiction. These memories make cocaine addicts vulnerable to relapse even after years of abstinence. Indeed, re-exposure to cues previously associated with cocaine often provokes cocaine craving that can trigger compulsive drug use. Making cocaine addiction a memory disease. Cocaine also causes other long-term effects on the brain. Chronic exposure to the drug alters the expression of several genes in the limbic system, which ultimately results in synaptic plasticity changes. A major player in this process seems to be a transcription factor (an enzyme that regulates gene expression) called deltafosb. Scientists have found that repeated administration of many kinds of drugs of abuse, included cocaine, increase the presence of this protein in the neurons of the striatum. Moreover, genetically engineered mice that overexpress the deltafosb gene show an enhanced addictive phenotype, linking directly the gene with drug addiction (McClung 2003). 3- The gateway hypothesis The existence of a developmental sequence of involvement in drugs is one of the best replicated findings in the epidemiology of drug use (Kandel D., 2002). Both in the United States and in other western societies, a regular sequence and stages of progression have been found. In this sequence, the use of cigarettes (nicotine) or alcohol precedes the use of marijuana (cannabis) and, in turn, the use of marijuana precedes the use of other illicit drugs. Very few individuals who have tried cocaine and heroin have not previously used marijuana; and the majority have used alcohol or cigarettes prior to their use of marijuana. Such behavioral regularities have given rise to the Gateway Hypothesis. However, in the 30 years

since publication of the original observation (Kandel D. & Faust, 1975), surprisingly little progress has been made in addressing three fundamental questions that derive from the observation that the use of one class of drug is followed by the use of another class. Thus, my laboratory decided to investigate (1) if the use of the first class of drugs, such as nicotine, is a cause of the use of the second class, such as cocaine, or whether the sequence is determined exclusively by availability of the drug or other social factors; (2) what biological mechanisms underlie this progression in drug use; and (3) why early use during adolescence leads to more extensive and chronic use than later onset of drug use post-adolescence. One reason there has been little progress in the mechanistic understanding of the Gateway Hypothesis is the difficulty of establishing causality in the context of non-experimental epidemiological data. One way to begin to address causality is to use animal models in mice to test epidemiological hypotheses. Mice provide the opportunity for testing directly the causal association between drugs assumed by the Gateway Hypothesis and for identifying underlying biological and behavioral mechanisms. While animal models cannot mimic the variety of cultural, social, and psychological factors that determine drug behavior in human populations (e.g., norms, peer influences, personal meanings, personal traits, etc), animal models can examine one of the fundamental questions that underlies the Gateway Hypothesis: Does prior use of a drug class per se increase the risk of the use of another drug class? In mice, this question can be asked in relation to well-defined prior experiences with specific drugs, independently of questions of access or any other social or legal constraints regulating and defining drug use. Alternate specifications of the sequential order of drug presentation can further help resolve the possibility that the ordered use between any two drugs is determined exclusively by social factors or by the availability of different

substances. In addition, because molecular biology and genetics can readily be used in mice, underlying mechanisms can in principle be identified. Finally, since initial drug involvement in human populations begins most often during adolescence, mouse models also allow one to explore age as a potentially important contributor to the Gateway Hypothesis. Insights from these investigations can in turn feedback and guide future epidemiological studies and even potentially suggest possible new avenues of intervention. 4- Experimental evidence supporting the Gateway Hypothesis The epidemiological finding that nicotine use (via tobacco smoking) often precedes the use of other drugs may indicate that nicotine has unique biological characteristics which underlie its ability to serve as one of the gateways to the use of other addictive drugs. We now have obtained direct evidence to support this component of the Gateway Hypothesis in male mice. We find that pre-exposure to nicotine enhances the subsequent molecular and behavioral response to cocaine, while the reverse does not hold. Pre-exposure to cocaine does not enhance response to nicotine. More specifically, chronic administration of nicotine causes upregulation of the nicotinic a7* and b2* receptors, and these types of receptors are required for cocaine-induced behavioral sensitization. Blocking these two types of receptors blocks the effects of cocaine. Nicotine also increases the expression of the transcription factor deltafosb, by altering the chromatin structure in the nucleus. Nicotine inhibits the enzymatic activity of HDACs, thus allowing higher expression of genes, deltafosb included. Moreover, nicotine enhances the effects of cocaine increasing locomotion activity in mice

following cocaine exposure and cocaine preference (Levine 2011) (Fig 6). Fig 6 Nicotine pretreatment increases cocaine effects. These results suggest that nicotine exposure rewires the brain at the molecular and cellular level to enhance the effect of cocaine. Thus, the new findings open a wide range of research and translational opportunities. References Kandel D, Faust R. (1975) Sequence and Stages in Patterns of Adolescent Drug Use. Arch Gen Psychiatry. 32(7):923-932.

Kandel, D. B. (Eds). (2002). Stages and pathways of drug involvement: Examining the gateway hypothesis. Cambridge, UK: Cambridge University Press. Kandel E.R, The molecular biology of memory: camp, PKA, CRE, CREB-1, CREB-2, and CPEB. Mol Brain. 2012 May 14;5(1):14 McClung, C. A, Nestler E. J, (2003) Regulation of gene expression and cocaine reward by CREB and FosB. Nature Neuroscience 6, 1208-1215. Amir Levine, Yanyou Huang, Bettina Drisaldi, Edmund A. Griffin, Jr., Daniela D. Pollak, Shiqin Xu, Deqi Yin, Christine Schaffran, Denise B. Kandel, Eric R. Kandel. Molecular Mechanism for a Gateway Drug: Epigenetic Changes Initiated by Nicotine Prime Gene Expression by Cocaine. Science Translational Medicine, 2011; 3 (107): 107ra109 DOI: